QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ascendiant-capital-maintains-buy-on-renovorx-raises-price-target-to-825

Ascendiant Capital analyst Edward Woo maintains RenovoRx (NASDAQ:RNXT) with a Buy and raises the price target from $8 to $8.25.

 renovorx-publishes-positive-early-stage-data-on-tamp-therapy-for-locally-advanced-pancreatic-cancer

Chemotherapy Delivered Via TAMP With Prior Chemoradiation Shows 27-Month Overall Survival; Ongoing Phase III Trial Evaluates Ta...

 ascendiant-capital-initiates-coverage-on-renovorx-with-buy-rating-announces-price-target-of-8

Ascendiant Capital analyst Edward Woo initiates coverage on RenovoRx (NASDAQ:RNXT) with a Buy rating and announces Price Tar...

 renovorx-ceo-updates-shareholder-letter

Dear Fellow RenovoRx Shareholders,The first quarter of 2024 marked a significant period in our company's evolution, and we ...

 renovorx-announces-publication-of-results-of-pre-clinical-studies-support-efficacy-and-drug-delivery-mechanism-potential-of-the-cos-tamp-therapy-platform-to-improve-targeted-cancer-drug-treatment-delivery

Data shows that the Trans-Arterial Micro-Perfusion (TAMP) platform increases intra-arterial pressure, improving drug delivery w...

 renovorx-executes-definitive-subscription-agreement-with-accredited-investors-for-111m-at-market-private-placement

Cash position now expected to fund current operating plan into 2026Financing provides cash runway to advance the ongoing pivota...

 alliance-global-partners-initiates-coverage-on-renovorx-with-buy-rating-announces-price-target-of-4

Alliance Global Partners analyst Scott Henry initiates coverage on RenovoRx (NASDAQ:RNXT) with a Buy rating and announces Pr...

 why-longboard-pharmaceuticals-shares-are-trading-higher-by-around-200-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Longboard Pharmaceuticals, Inc.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION